The Health Care M&A Monthly: Cash Is King–
Recent Dealmaking Influenced By Cash Considerations Cash is king proved to be a dominant theme in February’s health care M&A market: how to keep it, how to raise it and how to use it wisely. Some companies swapped products so they wouldn’t have to dig into cash...The Health Care M&A Monthly: January’s Health Care M&A Market–
Seventy-One Deals Announced Worth $73.6 Billion The merger and acquisition market in the health care industry for January 2009 posted a total of 71 deals, with transactions announced in each of the 13 sectors of the industry that we cover. Out of this amount, 43...The Health Care M&A Monthly: Pfizer Buys Wyeth For $68 Billion–
Acquisition Enlarges Biotech Pipeline And Revenues After several quarters of somewhat mall and dilatory acquisitions, Pfizer (NYSE: PFE) made a major announcement at the end of January. The company is buying competitor Wyeth (NYSE: WYE) for $68.0 billion. In doing...BIOTECH LEADS 2008 HEALTH CARE M&A TO NEAR RECORD LEVELS ACCORDING TO NEW REPORT FROM IRVING LEVIN ASSOCIATES, INC.
FOR IMMEDIATE RELEASE Stephen M. Monroe, Partner Sanford B. Steever, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT –January 16, 2009 – During 2008 and based on preliminary results, a total of 973 mergers and...Five-Year Trend Ends In Health Care Venture Capital, Reports Healthcare Corporate Finance News
FOR IMMEDIATE RELEASE Stephen M. Monroe, Partner Gretchen S. Swanson, Associate Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com Norwalk, CT – January 14, 2009—After five years of annual increases in the amount of venture...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
